Brandon Couillard
Stock Analyst at Wells Fargo
(4.27)
# 373
Out of 4,902 analysts
128
Total ratings
55.29%
Success rate
14.8%
Average return
Main Sectors:
Stocks Rated by Brandon Couillard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Downgrades: Equal-Weight | $420 → $330 | $288.67 | +14.32% | 4 | Jul 15, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Equal-Weight | $260 → $245 | $246.29 | -0.52% | 11 | Jun 9, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Equal-Weight | $260 → $245 | $250.66 | -2.26% | 10 | Jun 9, 2025 | |
| MLAB Mesa Laboratories | Maintains: Underweight | $120 → $100 | $70.62 | +41.60% | 2 | May 30, 2025 | |
| TECH Bio-Techne | Initiates: Overweight | $59 | $52.56 | +12.25% | 1 | May 30, 2025 | |
| MYGN Myriad Genetics | Downgrades: Equal-Weight | $22 → $6 | $4.69 | +27.93% | 2 | May 8, 2025 | |
| MTD Mettler-Toledo International | Maintains: Equal-Weight | $1,125 → $1,200 | $1,195.63 | +0.37% | 5 | May 5, 2025 | |
| WGS GeneDx Holdings | Maintains: Equal-Weight | $105 → $78 | $78.99 | -1.25% | 3 | May 1, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Overweight | $580 → $570 | $417.33 | +36.58% | 5 | Apr 24, 2025 | |
| A Agilent Technologies | Maintains: Hold | $135 → $116 | $114.65 | +1.18% | 22 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $130 → $102 | $93.43 | +9.17% | 2 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $60 | $40.91 | +46.66% | 3 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $22 | $13.32 | +65.23% | 4 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $280 → $240 | $191.74 | +25.17% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $260 | $189.33 | +37.33% | 11 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $77 → $80 | $69.20 | +15.62% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $28 → $24 | $12.13 | +97.86% | 2 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $85 | $51.74 | +64.28% | 16 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $180 | $121.60 | +48.03% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $10 | $2.41 | +315.80% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $30 → $23 | $19.40 | +18.56% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $0.74 | +1,656.99% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.15 | - | 11 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $2.84 | +287.32% | 2 | Oct 13, 2017 |
Waters
Jul 15, 2025
Downgrades: Equal-Weight
Price Target: $420 → $330
Current: $288.67
Upside: +14.32%
Bio-Rad Laboratories
Jun 9, 2025
Maintains: Equal-Weight
Price Target: $260 → $245
Current: $246.29
Upside: -0.52%
Bio-Rad Laboratories
Jun 9, 2025
Maintains: Equal-Weight
Price Target: $260 → $245
Current: $250.66
Upside: -2.26%
Mesa Laboratories
May 30, 2025
Maintains: Underweight
Price Target: $120 → $100
Current: $70.62
Upside: +41.60%
Bio-Techne
May 30, 2025
Initiates: Overweight
Price Target: $59
Current: $52.56
Upside: +12.25%
Myriad Genetics
May 8, 2025
Downgrades: Equal-Weight
Price Target: $22 → $6
Current: $4.69
Upside: +27.93%
Mettler-Toledo International
May 5, 2025
Maintains: Equal-Weight
Price Target: $1,125 → $1,200
Current: $1,195.63
Upside: +0.37%
GeneDx Holdings
May 1, 2025
Maintains: Equal-Weight
Price Target: $105 → $78
Current: $78.99
Upside: -1.25%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Overweight
Price Target: $580 → $570
Current: $417.33
Upside: +36.58%
Agilent Technologies
Apr 21, 2025
Maintains: Hold
Price Target: $135 → $116
Current: $114.65
Upside: +1.18%
Apr 17, 2025
Maintains: Equal-Weight
Price Target: $130 → $102
Current: $93.43
Upside: +9.17%
Apr 17, 2025
Maintains: Overweight
Price Target: $75 → $60
Current: $40.91
Upside: +46.66%
Apr 17, 2025
Maintains: Overweight
Price Target: $25 → $22
Current: $13.32
Upside: +65.23%
Jan 30, 2025
Maintains: Equal-Weight
Price Target: $280 → $240
Current: $191.74
Upside: +25.17%
Jan 23, 2025
Maintains: Buy
Price Target: $285 → $260
Current: $189.33
Upside: +37.33%
Jan 23, 2025
Maintains: Hold
Price Target: $77 → $80
Current: $69.20
Upside: +15.62%
Jan 15, 2025
Upgrades: Equal-Weight
Price Target: $28 → $24
Current: $12.13
Upside: +97.86%
Nov 6, 2024
Maintains: Buy
Price Target: $84 → $85
Current: $51.74
Upside: +64.28%
Aug 27, 2024
Initiates: Overweight
Price Target: $180
Current: $121.60
Upside: +48.03%
Aug 27, 2024
Initiates: Overweight
Price Target: $10
Current: $2.41
Upside: +315.80%
Feb 9, 2024
Downgrades: Hold
Price Target: $30 → $23
Current: $19.40
Upside: +18.56%
Jul 13, 2021
Initiates: Buy
Price Target: $13
Current: $0.74
Upside: +1,656.99%
Nov 2, 2017
Downgrades: Hold
Price Target: n/a
Current: $3.15
Upside: -
Oct 13, 2017
Maintains: Buy
Price Target: $9 → $11
Current: $2.84
Upside: +287.32%